Influence of local inflammation of the peritoneal membrane on diuresis and residual renal function in patients treated with peritoneal dialysis

Journal of Artificial Organs

Volumn 15, Issue 1, 2012, Pages 65-70

  Jelicic, Ivo ^a   Ljutic, Dragan ^a   Sain, Milenka ^a   Kovacic, Vedran ^a   Radic, Josipa ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Diuresis; Interleukin 6; Peritoneal dialysis; Residual renal function

Indexed keywords

ALBUMIN; CREATININE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PHOSPHORUS; POTASSIUM; UREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIURESIS; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIALYSIS SOLUTIONS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RECEPTORS, INTERLEUKIN-6;

EID: 84858704969     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-011-0603-7     Document Type: Article

References (29)

1. A Fusshoeller 2008 Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis Pediatr Nephrol 23 19 25 17638023 10.1007/s00467-007-0541-z (Pubitemid 350245968)
2. JD Williams KJ Craig N Topley C Von Ruhland M Fallon GR Newman RK Mackenzie GT Williams Peritoneal Biopsy Study Group 2002 Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol 13 470 479 11805177 (Pubitemid 34106290)
3. SJ Davies L Phillips AM Griffiths LH Russell PF Naish GI Russell 1998 What really happens to people on long-term peritoneal dialysis? Kidney Int 54 2207 2217 9853287 10.1046/j.1523-1755.1998.00180.x 1:STN:280: DyaK1M%2FntVequw%3D%3D (Pubitemid 28533651)
4. MS Park HA Lee WS Chu DH Yang SD Hwang 2000 Peritoneal accumulation of AGE and peritoneal membrane permeability Perit Dial Int 20 452 460 11007378 1:STN:280:DC%2BD3cvltFKqsg%3D%3D
5. P Steinvinkel P Barany O Heimburger R Pecoits-Filho B Lindholm 2002 Mortality, malnutrition and atherosclerosis in end-stage renal disease: what is the role of IL-6? Kidney Int 61 S103 S108 10.1046/j.1523-1755.61.s80.19.x
6. T Taga T Kishimoto 1997 Gp130 and the interleukin-6 family of cytokines Annu Rev Immunol 15 797 819 9143707 10.1146/annurev.immunol.15.1.797 1:CAS:528:DyaK2sXisVGitr8%3D (Pubitemid 27169299)
7. S Rose-John 2001 Coordination of interleukin-6 biology by membrane bound and soluble receptors Adv Exp Med Biol 495 145 151 11774558 10.1007/978-1-4615- 0685-0-19 1:CAS:528:DC%2BD38Xks1eltrk%3D (Pubitemid 34106928)
8. SA Jones S Horiuchi N Topley N Yamamoto G Fuller 2001 The soluble interleukin 6 receptor: mechanisms of production and implications in disease FAESB J 15 43 58 10.1096/fj.99-1003rev 1:CAS:528:DC%2BD3MXht1Sns7Y%3D (Pubitemid 32061655)
9. H Honda AR Qureshi O Heimbürger P Barany K Wang R Pecoits-Filho 2006 Serum albumin, C-reactive protein, interleukin-6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD Am J Kidney Dis 47 139 148 16377395 10.1053/j.ajkd.2005.09.014 1:CAS:528: DC%2BD28Xpt1elsw%3D%3D (Pubitemid 41828276)
10. G Tripepi F Mallamaci C Zoccali 2005 Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling J Am Soc Nephrol 16 Suppl 1 83 88 10.1681/ASN.2004110972 (Pubitemid 41725091)
11. R Pecoits-Filho P Barany B Lindholm O Heimburger P Stenvinkel 2002 Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment Nephrol Dial Transpl 17 1684 1688 10.1093/ndt/17.9.1684 1:CAS:528:DC%2BD38Xms1Klu78%3D (Pubitemid 35012175)
12. JM Bargman KE Thorpe DN Churchill CANUSA Peritoneal Dialysis Study Group 2001 Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study J Am Soc Nephrol 12 2158 2162 11562415 1:STN:280:DC%2BD3MrivV2msg%3D%3D (Pubitemid 32880353)
13. F Termorshuizen JC Korevaar FW Dekker JG van Manen EW Boeschoten RT Krediet NECOSAD Study Group 2003 The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 Am J Kidney Dis 41 1293 1302 12776283 10.1016/S0272- 6386(03)00362-7 (Pubitemid 36637986)
14. R Paniagua D Amato E Vonesh R Correa-Rotter A Ramos J Moran S Mujais Mexican Nephrology Collaborative Study Group 2002 Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial J Am Soc Nephrol 13 1307 1320 11961019 1:CAS:528:DC%2BD38XktFaitrs%3D (Pubitemid 34441412)
15. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT, NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15:1061-70. (Pubitemid 38375326)
16. P Tam 2009 Peritoneal dialysis and preservation of residual renal function Perit Dial Int 29 S108 S110 19270196
17. AY Wang CW Lam M Wang J Woo IH Chan SF Lui JE Sanderson PK Li 2005 Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients Am J Kidney Dis 45 715 729 15806475 10.1053/j.ajkd.2004.12.012 1:CAS:528:DC%2BD2MXjvVGhur4%3D (Pubitemid 40460760)
18. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transpl. 2002;17(Suppl 7):7-15.
19. R Pecoits-Filho MJ Carvalho P Steinvinkel B Lindholm O Heimburger 2006 Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis Perit Dial Int 26 53 63 16538876 1:CAS:528: DC%2BD28XlvVSmt7w%3D (Pubitemid 44339662)
20. AR Malik MA Little M Henriksson FW Tam EA Brown 2007 Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis J Nephrol 20 340 349 17557268 1:CAS:528:DC%2BD2sXhsVKgt7jL (Pubitemid 47570365)
21. D Zemel RJM Berge GCM Koomen DG Struijk RT Krediet 1993 Serum interleukin 6 in continuous ambulatory peritoneal dialysis in patients Nephron 64 320 321 8321371 10.1159/000187340 1:STN:280:DyaK3szgvFKlsw%3D%3D (Pubitemid 23153071)
22. SM Hurst TS Wilkinson RM McLoughlin S Jones S Horiuchi N Yamamoto, et al. 2001 IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation Immunity 14 705 714 11420041 10.1016/S1074-7613(01)00151-0 1:CAS:528:DC%2BD3MXkvFSltrY%3D (Pubitemid 32592418)
23. Leehey DJ, Szeto CC, Li PKT. Peritonitis and exit site infection. In: Daugirdas JT, Blake PG, Ing TS, editors. Handbook of dialysis. 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 2007. p. 417-39.
24. A Tranaeus O Heimburger B Lindholm 1989 Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications Perit Dial Int 9 179 190 2488363 1:STN:280: DyaK3M7ns1Shuw%3D%3D (Pubitemid 19238926)
25. A Rodrigues M Martins JC Korevaar S Silva JC Oliveira A Cabrita, et al. 2007 Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters Am J Nephrol 27 84 91 17284895 10.1159/000099332 1:CAS:528:DC%2BD2sXisFygsLY%3D (Pubitemid 46364545)
26. McCourt M, Wang JH, Sookhai S, Redmond HP. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg. 1999;134:1325-1331, discussion 1331-1332.
27. SH Han SC Lee SV Ahn JE Lee DK Kim TH Lee, et al. 2007 Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients Nephrol Dial Transplant 22 2653 2658 17517797 10.1093/ndt/gfm242 (Pubitemid 47365532)
28. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE. Novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002;62:639-47. (Pubitemid 34779779)
29. SH Chung O Heimburger B Lindholm 2008 Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern Semin Dial 21 7 10 18251948 10.1111/j.1525-139X.2007.00327.x